Difference between revisions of "Test"
Jump to navigation
Jump to search
| [unchecked revision] | [unchecked revision] |
| Line 1: | Line 1: | ||
| − | + | Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms | |
| − | * | + | *Acute Myeloid Leukemia (AML) with Recurrent Genetic Abnormalities |
| − | ** | + | **Acute Myeloid Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1 |
| + | **Acute Myeloid Leukemia (AML) with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11 | ||
| + | *Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes | ||
| + | **sub division | ||
***sub-sub-sub division | ***sub-sub-sub division | ||
Revision as of 15:39, 7 February 2021
Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms
- Acute Myeloid Leukemia (AML) with Recurrent Genetic Abnormalities
- Acute Myeloid Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1
- Acute Myeloid Leukemia (AML) with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11
- Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes
- sub division
- sub-sub-sub division
- sub division